MetaCardio cardiovascular and cerebrovascular metabolic function evaluation project adopts the high performance liquid chromatography tandem mass spectrometry technology platform to detect 12 markers at one time, so as to provide evaluation for 7 cardiovascular and cerebrovascular diseases and abnormal states, so as to achieve the purpose of primary prevention of cardiovascular and cerebrovascular diseases. The detection technology has the advantages of high sensitivity, strong specificity and short analysis time. MetaCardio also provides personalized health and targeted health intervention suggestions for each customer. The sampling method designed in this project is simple, and users can complete sample collection at home.
Homocysteine, betaine, choline, trimethylamine oxide, creatinine, carnitine, isoleucine, leucine, valine, phenylalanine, tyrosine, tryptophan
Coronary heart disease, dyslipidemia, stroke, myocardial infarction, heart failure, insulin resistance, atherosclerosis
© Copyright 2015-2022 Suzhou PANOMIX Biomedical Tech Co.,Ltd